Directa Plus (GB:DCTA) has released an update.
Directa Plus, a significant graphene nanoplatelets manufacturer, announced the successful passing of all resolutions at their recent Annual General Meeting (AGM) and General Meeting (GM), in relation to the Fundraising initiative unveiled on June 11, 2024. The Company, renowned for its eco-friendly and nontoxic graphene products, continues to innovate with its proprietary technology, catering to diverse consumer and industrial applications. The full results of the meeting’s resolutions will be available on the Directa Plus website for shareholders and interested parties.
For further insights into GB:DCTA stock, check out TipRanks’ Stock Analysis page.
